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THYROTOXICOSIS IN PREGNANCY 
VANNI CREMONA 
M.D., M.R.C.O.G. 
Thyroid function is closely interrelat-
ed with the development and function of 
the female genital organs. Myxoedema and 
cretinism delay the onset of menstruation 
and the development of secondary sexual 
characteristics. When menstruwtion is pre-
sent it tends to be irregular and infreq-
uent. In adult hypothyroidism menorrhagia 
may occur, while with hyperthyroidism 
oligomenorrhoea or amenorrhoea freq-
uently occur but menorrhagia is rare. The 
thyroid gland is affected by changes in rep-
roductive funcfion. Thyroid enlargement 
is six times as frequent in the postadoles-
cent woman as in man. It is apt to occur 
at puberty, in pregnancy and at the meno-
pause. Oestrogens are known to affect 
numerous parameters of thyroid function. 
Probably owing to an increase 'in thyroid 
binding globulin (TBG) the protein bound 
.iodine (PBI) is raised and the radioactive 
triodothyronin ('3iTa) red cell or resin 
uptake is decreased .This fact is of major 
clinical importance as the contraceptive 
pill or other oestrogen therapy may cause 
errors of judgement in the evaluation of 
thyroid function tests in cases of suspect-
ed throid dysfunction. 
Fertility is also affected by changes 
in thyroid function. Sterility is common 
in myxoedema although 'instances of preg-
nancy in severe untreated hypothyroidism 
have been reported. When pregnancy res-
ults, abortion and stillbirths are common. 
Even when the pregnancy is carried suc-
cessfully to term, congenital goitre may 
occur. Moreover a high incidence of deve-
lopmental abnormalities is seen in euthy-
roid offspr'ing of hypothryoid mothers. Un-
treated thyrotoxicosis is also associated 
with a decreased fertility rate. Keynes 
(1952) reported a fertility rate of 52.5% 
in thyrotoxic women before operation 
compared with a normal rate of 70%. 
Thyrotoxicosis is ,a disease of un-
known aetiology with a striking genetic or 
familial incidence. The condition affects 
women more often than men and is pre-
dominantly a disease of the childbear.ing 
era. In spite of this it is rarely found in 
association w'ith pregnancy. The incidence 
in reported series varies widely. Silver 
(1965) comparing the incidence of sever,al 
series found that the overall mean inci-
dence of thyrotoxicosis in pregnancy is 
0.047%. 
Before considering the treatment of 
thyrotoxicosis in pregnancy it is important 
to determine what effect thyrotoxicosis 
has on pregnancy, the changes in thyroid 
function that occur in normal pregnancy 
and the effect of pregnancy on thyrotoxi-
cosis. 
Effect of Thyrotoxicosis on Pregnancy 
There is genera,l agreement that un-
controlled thyrotoxicosis predisposes to 
abortion, premature delivery and stillbirth 
and that the risks are proportionate to the 
severity of the thyrotoxicosis. Proper con-
trol eliminates most of these risks as ris 
seen in most modern series. In the past 
the incidence of pre-eclampsia seems to 
have been very high in pregnancy complic-
ated by thyrotoxicosis. McLaughin and 
McGoogen (1943) reported an inc'idence 
of 62% in their series of only 19 cases. In 
contradistinction in Hawe and Francis' 
series of 70 patients only 4 (5.7%) deve-
loped pre-eclampsia. With modern treat-
ment this complication does not occur 
more commonly than in euthyroid preg-
nant women. 
The foetus is not usually affected by 
thyrotoxicosis, but rare cases of congenital 
thyrotoxicosis or exophthalmos have been 
reported. The condition is usually benign 
and settles spontaneously or with minimal 
treatment. 
Effect of pregnancy 
on thyroid function 
Most of the symptoms and signs as-
sociated with hyperthyroidism are present 
in a lesser or gre,ater degree in pregnancy. 
Many clinical features are common to 
pregnancy and to thyrotoxicosis. These in-
clude increased cardiac action, accelerated 
peripheral circulation, and decreased heat 
tolerance. The thyroid gland often enlar-
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ges during pregnancy. This was recognised 
by the ancient Egyptians who used it as 
a test Jor pregnancy by tying the stem of 
.a plant round a woman's neck. Pregnancy 
caused the stem to break. Few well con-
trolled trials into the incidence of goitre 
in pregnancy have been reported. Crook 
et al. (1964) reporting from Aberdeen 
found an incidence of 70% in pregnant 
women against an incidence of 37% in 
non--pregnant controls. They a,lso noted 
that the 'incidence was constant through· 
out pregnancy. 
There are very few reports on the 
histological changes in the thyroid gland 
during normal pregnancy. Stoffler (1957) 
studied the thyroid glands of 65 pregnant 
women at autopsy and reviewed a furtJher 
28 cases from the literature. He found no 
evidence of increased thyroid weight and 
suggested that any increase in size must 
be due to hyperaemia. T1he histological p'ic-
ture of enlarged follicles fuIl of thin colloid 
with vacuolisation and an epithelium which 
is generally hypertrophic led him to con-
clude that there is increased activity of the 
thyro'id gland during pregnancy. 
The basal metaboric rate is increased 
during pregnancy. The rise is apparent 
after the fourth or fifth month and gra-
dually rises until term when it is raised 
about 20% above non-pregnant levels. At-
temps to correlate this phenomenon with 
changes have f.ailed. 
TAftLE I 
Determination Non-pregnant normal Pregnant normal 
PBI 4.0-7.5 14t% 6.5-11.5 }Lg% 
----
BEl 3.2-6.5 /Lg% 5.5-10.5 }Lg% 
Ta RBC uptake 11-17% < 10% 
-------
Ta Resin uptake 25-30% < 10% 
-- ---
Free thyroxine factor 0.384 (±0.0843) 0.375 (±0.103) 
Free thyrox,ine 1.4-2.5 iffi/Lg% 1.4-2.5 m}Lg% 
Normal values for thyroid function tests in pregnancy. 
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The increased oxygen uptake in pre-
gnancy is probably due to an increase lin 
protoplasm'ic mass and the increased car-
diac and respiratory work which occurs 
during pregnancy. 
PBI also rises e.arly in pregnancy to 
levels consistent with hyperthyroid states. 
Increased levels are found as early as 3 to 
6 weeks of gestation. Man (1961) reported 
that the levels are consistently raised by 
the 16th week of pregnancy. Butanol ex-
tractable iodine (BEl) which reflects the 
total serum thyroxdne level shows a similar 
increase 'in the binding capacity of the TBG 
either due 'to a quantitative increase in 
the protein or due to a qualitative altera-
tion in its binding capacity. This increase in 
binding capacity is reflected by a decrease 
uptake of 131Ta by red cells or resin which 
is seen as early as the fourth week of pre-
gnancy. It is believed that the increase in 
thyroxine binding capacity, which accounts 
for the rise in PBI and BEl, is secondary 
to the effects of oestrogens. However, re-
cent reports do not confirm th·is. 
Radioactive 11.'2 which has a half life 
of only 77 hours has been used to study 
thyroid activity during pregnancy. Halnan 
(1958) found that there is an increased up-
take of iodine by the thyroid gland during 
p,regnancy. In a later more extensive study 
by Aboul-K!hair (1964), the plasma inorga-
nic I level was found to be low throughout 
pregnancy. This 'is due to an increased 
renal clearance of I which is high through-
out pregnancy. This causes ,a relative iod-
ine deficiency in the ,immediate vicinity of 
the thyroid gland with the result that clear-
ance of I by the thyroid is increased 'in 
order to maintain the absolute iodine up-
take within euthYlroid limits. These find-
dngs suggest that in normal pregnancy 
there occurs no increase in thyroid hor-
mone production. 
Recent advances in methods ava'ilable 
for studying thyroid function have con-
firmed that normal pregnant women are 
euthyroid. Free thyroxine factor, which is 
based on a calculation between l3lTa RBC 
or resin uptake of PBI levels and ref-
lects the level of free thyroxine in the 
serum, shows no significant difference bet-
ween normal pregnant and non-pregnant 
women. Free thyroxine estimations have 
also been performed and confirm these re-
sults, It seems therefore, that the usual 
tests of thyroid function are distorted by 
the metabolic and cardiovascular changes 
which occur during pregnancy and that 
any enlargement of the thyroid gland is 
due to the relative iodine deficiency. 
These metabolic and cardiovascular 
changes make the diagnosis of thyrotoxi-
cosis during pregnancy difficult. As we 
have seen before, certa'in clinical features 
of p~egnancy and thyrotoxicosis are re-
markably similar. However, the more 
marked these clinical features, the more 
likely is the probab:.Iity of co-existing 
thyrotoxicosis, especially a persistently 
high sleeping pulse rate, fa'ilure to gain 
weight despite good appetite, excessive 
sweating, tremor, and a considerably en-
larged pulsatile thyroid gland. The pre-
sence of exophthalmos may prov:de valu-
able evidence as does a history of symp-
toms which preceded the onset of pregnan-
cy. Laboratory aids ,are not usuaJ:ly help-
ful especially in mild oases. The use of 1l:ll 
'is oontraindioated, but 1'32 may be useful 
in excepfional circumstances. Halman cal-
culated that with a dose of 6 /LC of 1'32 the 
foetal thyroid is exposed to only 0.01 to 
0.06 r.ads. and the foetal and maternal 
gonads to less than 0.001 rads. l3lTa uptake 
studies and espeCially the calculation of 
free thyroxine factor appear to reflect the 
true state of thyroid function and may 
prove to be the best guide as to the seve-
rity of the thyrotoxicosis and to the level 
of control during treatment. 
Effects of pr,egnancy 
on thyrotoxicosis 
Thyrotoxicosis often shows sponta-
neous changes 'in severity and this makes 
interpretation of the effect of pregnancy 
difficult to evalua,te. There i's no general 
agreement, the camp being equally divided 
between those who consider that adverse 
effects may occur and those who ma·intain 
that pregnancy has a favourable effect on 
thyrotoxicosis. However, as Hawe and 
Francis remark there is an increased risk 
of thyroid orisls during or immediately 
after delivery. 
Treatment of thyrotoxicosis 
during pregnancy 
During pregnancy two plans of treat-
ment axe available for the control of thyro-
toxicosis. One is to control the hyper-
thyroidism with antithyroid drugs through-
out pregnancy. The alternative is to per-
form subtotal thyroidectomy after control-
ling the disease w"i-th a short course of 
antithyroid drugs or iodine. Radioactive 
iodine which is the method of choice in 
patients ove.r 45 years of age, is absolutely 
contraindica.ted during p'regnancy. The 
isotope crosses the placental barrier and 
is accumulMed with great avidity by the 
foetal thyroid af.ter the first trimester. The 
risk of damage to the foetus is very real 
especially as the thyroid glands of infants 
are known to be unusually sensitive to 
radioiodine. Russell et al. (1957) reported 
two cases of severe hypothyroidism in 
·infants whose mothers were given 1'31 dur-
ing the 13th week of pregnancy. 
Medical treatment 
Control of thyrotoxicosis with anti-
thyroid drugs throughout the pregnancy 
is usually cons·idered as the treatment of 
choice. The dosage varies from patient to 
patient. The general aim is to obt.ain con-
trol of the hypefithyroid state and then re-
duce the dose to the minima.! maintenance 
level. In judging the level of control one 
must always be aware of the apparently 
raised levels of thyroid function charaoter-
istic of normal pregnancy. The usual diffi-
culties of controlling hyperthyroidism are 
enhanced during pregnancy. Over-treat-
ment may endanger the foetus and under-
treatment may lead to an exacerbation of 
maternal thyrotoxicosis; both situations 
are associated with an increased fisk of 
foetal loss. In the interests of the foetus 
the usual praotice is to reduce or stop anti-
thyroid drugs during the latter months of 
pregnancy. Unfor.tunately due to occasio-
nal unexpected early rel3'pses this is not 
always possible. 
Antithyroid drugs are known to cross 
the placental barrier and depress the foe-
tal thyroid gland. This re suIts in ·increased 
production of thyroid stimulating hormone 
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(TSH) and hyperplasia of the foetal gland. 
Foetal goitre is usually transient and sub-
sides spontaneously; however, several in-
stances of a large goitre leading to neo-
natal death from tracheal compression 
have been reoorded and several cretins 
have resulted from the use of antithyroid 
drugs. Furthermore, antithyroid drugs a're 
excreted in the milk and therefore breast 
feeding is contraindicated during their use. 
In spite of these difficulties some ex-
cellent series have been reported. Astwood 
(1951) treated 19 patients with propyl-
thiouracil or Carb:mazole, substantially 
reduc"ing the dosage during the second half 
of pregnancy. He obtained 22 live infants 
from 22 pregnancies and no foetal goitres. 
Piper and Rosen (1954) following a similar 
regime recorded four abortions and one 
stillbirth among 16 pregnancies. They re-
viewed the literature and were able to find 
records of 83 pregnancies during wh'ich 
antithyroid drugs were used to oontrol 
hyperthyroidism, with ,a foetal loss of 6. 
Of the 77 viable infants 14 had goitres. 
S'imHa'r difficulties were experienced by 
Becker and Suddith (1959) and Hawe and 
F'rancis (1962). Howeve.r, Herberrt (1965) 
reported a series of 32 pregnancies during 
which antithyroid drugs were used follow-
ing the usual regime, adding USP thyroid 
120-180 mg. when the thyrotoxicosis was 
under oontrol. They reported a foetal l'Oss 
of only three and no instance of foetal 
goitre. The addition of thyroid hormone 
may be useful 'in avoiding maternal hypo-
thyroidism, but it is doubtful what bene-
ficial effects this has on the foetus as 
thyroxine crosses the placental barrier 
very slowly (Myant 1958). 
Table H summarises the results of 
several series where antithyroid drugs were 
used to control thyrotoxicosis in pregnan-
cy. Out of a total of 245 pregnancies, the 
foetal loss was 33 (13.5%); two of these 
were neonatal deaths due to a suffocative 
goitre. Of the 212 live 'infants 23 had 
goitres and 2 were cretins, an incidence 
of goitre of 9%. 
Surgery 
Subtotal thyroidectomy has been per-
formed for the control of thyrotoxicosis 
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TABLE 11 
Author I No. pregs. Foetal loss Viable infants No. goitres _ .. _ ... 
Series prior to 1954 
according to 
P~per and Rosen 83 6 77 15 
_.-
Piper and Rosen (1954) 16 5 11 0 
Becker and Suddith 2 
(1959) 34 9 25 1 cretin 
--- . 
Hawe and Frances 
(1962) 39 5 34 1 cretin 
Burrow (196'5) 41 5 36 5 
-------
Herbst (1965) 32 3 29 0 
-
TOTAL 245 33 (13.5%) 212 24 (9%) 
-. 
Foetal loss and incidence of goitre 
in series treated by antithyroid drugs. 
during pregnancy since the beginning of 
this century. Almost consistently good re-
sults have been obtained. 1'he operation is 
usuaHy peTformed dur'ing the 2nd trimes-
ter due to the possibility of C'aus'ing mis-
carriage if it is perf'ormed earlier. Even 
when performed during the first trimester 
instances of miscardage following opera-
tion are na~e. Prior to the introduct'ion of 
the antithywid drugs patients were pre-
pared with iodine. Piper and Ros1en (1954) 
collected 122 cases from the literature with 
a foetal loss of four. No foetal abnormaJi-
ties occurred. 
More recently antithyroid drugs have 
been used to obtain control of the hyper-
thYJoidism as subtotal thyroidectomy is 
safer if performed on eu1!hyroid patients. 
Lugol's iodine is given for 1-2 weeks prior 
.to operation in order to diminish the in-
creased vascularity of the thyroid gland 
which results from the use of anfithyroid 
drugs. Following this regime most authors 
report good results. Bell and Hall (1960) 
suggest that the use of thyroid replace-
ment therapy following operation is worth-
while as results seem to be greatly im-
proved. They treated 21 pregnant patients 
with subtotal thyroidectomy following 
antithyroid drug therapy. In this gl'OUp of 
patients the~e were 4 ;abortions and 1 sfill-
birth. Following this exp'erience they treat-
ed a further 21 pregnant patients with a 
simi.lar regime, but pTescribed dessic.a.ted 
thyroid post-operatively Ullltil term. dhly 
one infant, a stillb:irth, was lost. Other 
authors (iHawe and Francis) have not con-
firmed this adv'antage of thyroid replace-
ment therapy, but its use is justified as 
hypothYl'olidism may occur after surgery. 
Table III summarii'ses the ·results of 
several series where thyrotoxioOSlis was 
tJ1eated by subtotal thyroidectomy during 
pregnancy following control with iodine 
alone or with antithyroid drugs. Out of 
300 pregnancies the foetal loss was only 
22 (7.3%). No goitres occurred. Only one 
inf<ant, a mongol, showed congenital .abnor-
maHties. 
125 
TABLE III 
Author No. Pregs. Foetal loss Viable infants 
CoUected seflies according 
to Pliper and Rosen (1954) 122 4 118 
Dailey and Benson (1952) 17 3 14 
Stoffler (1957) 21 3 18 
Holt (1959) 3 0 3 
Becker and SutddH:,h (1959) 8 1 7 
Bell and Hall U96O) 42 6 36 
Lan~e (1961) 31 1 30 
Hawe (1965) 38 2 36 
------
Hamilton (1968) 18 2 16 
TOTAL 300 22 (7.3%) 278 
Foetal loss in s~ries treated with subtotal thyroidectomy. 
Discussion 
1'hese figures provide g'Ood ev,tdence 
of the slafety of subtotal 1!hyrordectomy for 
the mother and ch'ild. OcC'asional maternal 
deaths have occurred foHowing surgery 
(Stoffler 1959), but maternal deaths have 
als'O been recorded with medical treatment 
(Hawe and Frands 1962). AHhough the 
numbers are small and not suitable for sta-
tistical analys'is the rate 'Of f'Oetial ,loss and 
of neonatal mortaHty and morbidity are 
generaHy lower anJd more consIstent fol-
lowing surgery, than with antithyroid 
drugs. It appears 1!hiat operation during 
pregnancy does not increase the r'isk or 
adversely affect 1!he fO'etus and, therefore, 
most of the pros and cons which affect the 
choice of treatment in young non-pregnant 
patients are valid dufling pregnancy. 
At present the choice of treatment is 
la,rgely determined by whether the p.a1lient 
is referred to a surgeon or a physician. 
Most physicians regard medical treatment 
as the method of choice in pregnancy 
(Crooke and Wayne 1960). W'ith good me-
dica,l care it is possible to ()bta'in good 
results (AstwoOld 1951, Herbst 1'965), but 
from time to time difficu1tres al"ise which 
may be outside thecont'rol of the clinician 
espedally as treatment ,inv,olves a compro-
mise between !the inte,res,ts of the mother 
and 'of the foetus. Moreover the recurrence 
rate requ'irling 8ubtotal
'
thYrO'rdectomy, fol-
lowing delivery, is high,QPiper and Rosen 
1954, Becker and Suddith 1959, Hawe and 
Francis 1962). 
Subtotal thyroidectomy does not have 
many of these disadvantages. Fo'llowing 
,operation the patient quickly returns to a 
euthyroid state, the pregnancy will then 
pJ10ceed as in any normal patient and 
bl'east feeding is not restricted. Moreover 
;the recurrence rate after 'Opem1lion is ,low 
anJd subsequent pregnancies are not com-
plIcated by the persistence of 1!he hyper-
thyroid state. There are ,certain qua:lifica-
tions which have to be fulfilled prior to 
undertaking surgery. The diagnosis, of 
course, must be assured; this avoids unne-
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cessary operations on the mildly toxic pa-
tient in whom the diagnosis in pre~nancy 
may be very difficult and who might re-
cover spontaneously. The patient must be 
seen early in pregnancy as oVherwise not 
enough time is avai'lable to make the pa-
tient euthyroid before operation. No con-
traindications to operation must be pre-
sent. 
In the final analysis the medical and 
surgical facilities available and the special 
c~rcumstances of each indivrdual patient 
will determine the management of a par-
ticular case. However, subtotal thyroidec-
tomy performed by expe,rienced surgeons 
appears to offer better prospects to the 
foetus and the mother. 
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cribing some iUness Which affects only a 
few and per1haps only.Hghtly. lrt all comes 
back to the same thing: we must foster 
our linlks because Vhey are es,sentlal for 
the increase of our knowledge and this 
knowledge will serve us again to improve 
our m'edica'l learning. What we must not 
be ils an island in any sense except the 
geographical one. No one in his senses 
will deny the value of contacts with every 
country, espeCially tJhe historic countries 
of Europe which have civilised the world, 
but we must make the best of t:lhat acci-
dent w!hioh made us one with the country 
that is now what Athens was two thou-
sand years ago. 
